Navigation Links
Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
Date:12/4/2008

WALTHAM, Mass., Dec. 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that Jon Russell, Vice President, Finance, will attend the upcoming RBC Capital Markets 2008 Healthcare Conference being held December 10-11, 2008 at the Westin Times Square Hotel in New York. Mr. Russell's presentation is scheduled for Thursday, December 11, 2008 at 9:00 a.m. and will be made available to the public through a webcast accessible through the Company's website at http://www.invmed.com/investors.cfm and through RBC Capital Markets' website at http://www.wsw.com/webcast/rbc95/panel21/. A replay of the webcast will be available via the links above for 30 days. During his presentation, Mr. Russell may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

For more information about Inverness Medical Innovations, please visit our website at www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
2. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
3. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
4. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
5. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
6. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
7. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
8. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
9. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
10. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
11. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...ltrasonic cleaner is faster, safer and more thorou...s used in healthcare facilities. Improved cleaning...rough reuse of instruments are added benefits of u...th Orange, NJ (PRWEB) November 10, 2009 -- Infecti...ruments is a critical step in preventing infection...
(Date:11/10/2009)...possible to achieve exceptionally smooth surface f...erials such as ceramics, carbide and hardened tool...nd Flex-Hone® honing tool from Brush Researc...es (PRWEB) November 10, 2009 -- Using exclusive, s...ds of flexible filaments, the Diamond Flex-Hone is...
(Date:11/10/2009)... Nuamah, P.C., a Seattle law firm practicing perso..., has unveiled a new website. Residents of Washin...t the firm at www.carringtonnuamah.com . , ...ber 10, 2009 -- Seattle Law Firm Carrington Nuamah...onnuamah.com . Lawyers Andrew Carrington and Nich...
(Date:11/10/2009)...School of Public Health researchers will present N... Health Association,s annual meeting in Philadelph...h national recommendations that a physician screen...rival to the Emergency Department (ED). , Additi...ientists are highlighted below. , Disparities i...
(Date:11/9/2009)...orts, the worldwide leader in sports surfacing, en...with a more complete and innovative range of sport...ooring experts and the launch of www.tarkettsport...ovember 9, 2009 -- Tarkett Sports, redesigned line... includes hardwood and synthetic basketball, volle...
Breaking Medicine News(10 mins):Health News:Ultrasonic Cleaner from Tovatech Plays Key Role in World Health Organization's Guidelines for Infection Control 2Health News:Ultrasonic Cleaner from Tovatech Plays Key Role in World Health Organization's Guidelines for Infection Control 3Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:Seattle Law Firm Carrington Nuamah Launches New Website for Personal Injury, Bankruptcy, Immigration and Estate Law 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2
...SBORO, N.J., Dec. 12 Yesterday, the U.S. Court of...ted the Drug Enforcement,Administration,s (DEA) 20...,to dispense controlled substances. Wedgewood has ... the DEA,s denial of Wedgewood,s petition for,reco...
...NGTON, Dec. 12 Red Cross volunteer,Krysta Leigh M...platform,series from mtvU, MTV,s 24-hour college n...llege campuses nationwide. Krysta details her pass.../www.newscom.com/cgi-bin/prnh/20071212/DC09732 ),...
...e spine has evolved to better accommodate pregnanc...lthDay News) -- Given that a woman,s abdominal mas...racle that such a significant shift in gravity doe...act works. , According to researchers, the female ...
...CHESTER, Minn. -- When a vaccine to prevent shingl... Administration recommended the vaccine for people...ut two issues -- the vaccines cost and the percept...accine. This uncertainty prompted a group of resea...
...overnment Officials Will Explain Regulatory Plans ...b. 28-29 in Washington, DC., WASHINGTON, Dec. 12 ...0 billion in manufactured goods last year,accordin... from more than $3 billion in 2006. And industry e...
...RDAM, The Netherlands, Dec. 12 Agendia makes its,...able to U.S. patients,after receiving two clearanc... its test. The first clearance in February of this...dia received,a second clearance for the test in co...
Other Medicine News:Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 2Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 3Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 4Health News:Red Cross Blood Donor and Volunteer Featured on mtvU's 'CAUSE EFFECT' 2Health News:Evolution Tips the Balance in Mom's Favor 2Health News:Evolution Tips the Balance in Mom's Favor 3Health News:Mayo Clinic article offers data about shingles virus 2Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 4Health News:Agendia's MammaPrint(R), the Only FDA-Cleared Breast Cancer Prognosis Test, is Now Widely Available to U.S. Patients 2
(Date:11/9/2009)...l., Nov. 9 Landauer, In... and environmental radiation monitoring services, ... in accordance with its long-term strategic priori...itions of Global Physics Solutions, Inc. (GPS) and..., President and CEO of Landauer. "These acquisitio...
(Date:11/9/2009)..., Nov. 9 /PRNewswire-Asia-FirstCall/ -- American O...Company" or "AOBO"), a pharmaceutical,company dedi... manufacture and,commercialization of a broad rang...ducts, today announced that it plans to release th...mber 16, 2009, after the market closes. , ...
(Date:11/9/2009)...v. 9 Patent attorneys Cheryl Lilje... J. D., will showcase Stipkala LLC at the Texas Li...will be held at the Institute of Molecular Medicin...ce provides a platform for cutting-edge companies ...rs, and will feature keynote addresses and panel d...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Colorectal cancer 9090 1Desert rhubarb a self irrigating plant 9087 1Desert rhubarb a self irrigating plant 9087 2NIST issues human milk and blood serum SRMs for contaminant measurements 9083 1NIST issues human milk and blood serum SRMs for contaminant measurements 9083 2
...hen leading,biochemists get together to challenge ...dible new drug therapies are born. Recently, this ...cientists challenged the concept behind,the leadin...mpacts millions,of Americans. They saw the side ef... weight gain, and went to work on a hypothesis tha...
...tance Predisposes Patients to High...J., March 24 New BARACLUDE(R),(entecavir) data pr...ce of,resistance in nucleoside-naive patients thro...ve chronic hepatitis B patients analyzed, no addit...ar (n=108). Through five years,of treatment, the c...
Other Medicine Technology:BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 3BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 5BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 6
...Non-Sterile Howland lock handle - Chrome-plated br...lity standard laryngoscope handles that are compat...tured to ISO 7673 standards. The designs of these ... years of use the world over to minimize maintenan...
...inless steel. Lamp supplied with blade. Rusch offe...ncandescent laryngoscope blades. The designs of th...any years of use the world over to minimize mainte...ing specifications from the finest surgical grade ...
...e. Stainless steel. Lamp supplied with blade. Rusc...dard incandescent laryngoscope blades. The designs...ough many years of use the world over to minimize ... exacting specifications from the finest surgical ...
...lied with blade. The I.V. Macintosh blade is conca...ualization. Rusch offers a reliable tradition of h...des. The designs of these blades have been continu...ver to minimize maintenance requirements. They are...
Medicine Products: